Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child

M. Arico, G. Bossi, C. Livieri, E. Raiteri, F. Severi

Research output: Contribution to journalArticle

Abstract

Adrenocortical carcinoma (ACC) in childhood is a rare tumor with high fatality rate. Available reports provide event free survival rates ranging between 10 to 50%. Optimal treatment has not yet been established; surgery plays a major role, and the value of adjuvant chemotherapy needs to be evaluated further, especially in children who develop recurrent disease and those with metastases at diagnosis. Optimal therapy of ACC has not been established. Surgery has been curative after complete tumor resection. Children with inoperable, recurrent and metastatic ACC have been treated with O,P'DDD, with response rates ranging from 10 to 60% in different series [7, 11-20]. Radiotherapy [21] and other anti-cancer drugs have been used [4-22] but their efficacy has not been established. Combination chemotherapy containing oncovin, cisPlatinum, epipodophyllotoxin and cyclophosphamide (OPEC) produced regression of metastatic ACC in a 5-year-old male [23]. We report one girl with relapsed disseminated ACC who showed good, even if temporary, control of the disease, with disappearance of lung, liver and spleen metastases, and marked reduction of the adrenal mass, following combined chemotherapy according to the 'eight-drugs-in-one-day' protocol.

Original languageEnglish
Pages (from-to)246-248
Number of pages3
JournalMedical and Pediatric Oncology
Volume20
Issue number3
DOIs
Publication statusPublished - 1992

Fingerprint

Adrenocortical Carcinoma
Drug Therapy
Podophyllotoxin
Neoplasm Metastasis
Dichlorodiphenyldichloroethane
Neoplasms
Vincristine
Adjuvant Chemotherapy
Combination Drug Therapy
Pharmaceutical Preparations
Cyclophosphamide
Disease-Free Survival
Radiotherapy
Spleen
Survival Rate
Lung
Liver
Therapeutics

Keywords

  • adrenal cortical carcinoma
  • chemotherapy
  • childhood

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child. / Arico, M.; Bossi, G.; Livieri, C.; Raiteri, E.; Severi, F.

In: Medical and Pediatric Oncology, Vol. 20, No. 3, 1992, p. 246-248.

Research output: Contribution to journalArticle

Arico, M. ; Bossi, G. ; Livieri, C. ; Raiteri, E. ; Severi, F. / Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child. In: Medical and Pediatric Oncology. 1992 ; Vol. 20, No. 3. pp. 246-248.
@article{466b6c19e97a419cbdc709cbbbb4b7fa,
title = "Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child",
abstract = "Adrenocortical carcinoma (ACC) in childhood is a rare tumor with high fatality rate. Available reports provide event free survival rates ranging between 10 to 50{\%}. Optimal treatment has not yet been established; surgery plays a major role, and the value of adjuvant chemotherapy needs to be evaluated further, especially in children who develop recurrent disease and those with metastases at diagnosis. Optimal therapy of ACC has not been established. Surgery has been curative after complete tumor resection. Children with inoperable, recurrent and metastatic ACC have been treated with O,P'DDD, with response rates ranging from 10 to 60{\%} in different series [7, 11-20]. Radiotherapy [21] and other anti-cancer drugs have been used [4-22] but their efficacy has not been established. Combination chemotherapy containing oncovin, cisPlatinum, epipodophyllotoxin and cyclophosphamide (OPEC) produced regression of metastatic ACC in a 5-year-old male [23]. We report one girl with relapsed disseminated ACC who showed good, even if temporary, control of the disease, with disappearance of lung, liver and spleen metastases, and marked reduction of the adrenal mass, following combined chemotherapy according to the 'eight-drugs-in-one-day' protocol.",
keywords = "adrenal cortical carcinoma, chemotherapy, childhood",
author = "M. Arico and G. Bossi and C. Livieri and E. Raiteri and F. Severi",
year = "1992",
doi = "10.1002/mpo.2950200314",
language = "English",
volume = "20",
pages = "246--248",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child

AU - Arico, M.

AU - Bossi, G.

AU - Livieri, C.

AU - Raiteri, E.

AU - Severi, F.

PY - 1992

Y1 - 1992

N2 - Adrenocortical carcinoma (ACC) in childhood is a rare tumor with high fatality rate. Available reports provide event free survival rates ranging between 10 to 50%. Optimal treatment has not yet been established; surgery plays a major role, and the value of adjuvant chemotherapy needs to be evaluated further, especially in children who develop recurrent disease and those with metastases at diagnosis. Optimal therapy of ACC has not been established. Surgery has been curative after complete tumor resection. Children with inoperable, recurrent and metastatic ACC have been treated with O,P'DDD, with response rates ranging from 10 to 60% in different series [7, 11-20]. Radiotherapy [21] and other anti-cancer drugs have been used [4-22] but their efficacy has not been established. Combination chemotherapy containing oncovin, cisPlatinum, epipodophyllotoxin and cyclophosphamide (OPEC) produced regression of metastatic ACC in a 5-year-old male [23]. We report one girl with relapsed disseminated ACC who showed good, even if temporary, control of the disease, with disappearance of lung, liver and spleen metastases, and marked reduction of the adrenal mass, following combined chemotherapy according to the 'eight-drugs-in-one-day' protocol.

AB - Adrenocortical carcinoma (ACC) in childhood is a rare tumor with high fatality rate. Available reports provide event free survival rates ranging between 10 to 50%. Optimal treatment has not yet been established; surgery plays a major role, and the value of adjuvant chemotherapy needs to be evaluated further, especially in children who develop recurrent disease and those with metastases at diagnosis. Optimal therapy of ACC has not been established. Surgery has been curative after complete tumor resection. Children with inoperable, recurrent and metastatic ACC have been treated with O,P'DDD, with response rates ranging from 10 to 60% in different series [7, 11-20]. Radiotherapy [21] and other anti-cancer drugs have been used [4-22] but their efficacy has not been established. Combination chemotherapy containing oncovin, cisPlatinum, epipodophyllotoxin and cyclophosphamide (OPEC) produced regression of metastatic ACC in a 5-year-old male [23]. We report one girl with relapsed disseminated ACC who showed good, even if temporary, control of the disease, with disappearance of lung, liver and spleen metastases, and marked reduction of the adrenal mass, following combined chemotherapy according to the 'eight-drugs-in-one-day' protocol.

KW - adrenal cortical carcinoma

KW - chemotherapy

KW - childhood

UR - http://www.scopus.com/inward/record.url?scp=0026667167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026667167&partnerID=8YFLogxK

U2 - 10.1002/mpo.2950200314

DO - 10.1002/mpo.2950200314

M3 - Article

C2 - 1574038

AN - SCOPUS:0026667167

VL - 20

SP - 246

EP - 248

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -